478 related articles for article (PubMed ID: 17161355)
1. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses.
Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281
[TBL] [Abstract][Full Text] [Related]
3. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L
Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
[TBL] [Abstract][Full Text] [Related]
4. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
[TBL] [Abstract][Full Text] [Related]
5. Role of dendritic cells in the context of acute cellular rejection: comparison between tacrolimus- or cyclosporine A-treated heart transplanted recipients.
John K; Dieterlen MT; Tarnok A; Garbade J; Bittner HB; Mohr FW; Barten MJ
Cytometry B Clin Cytom; 2014 Sep; 86(5):362-7. PubMed ID: 24668729
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
7. Conversion to sirolimus in renal transplant recipients: a single-center experience.
Yelken B; Caliskan Y; Ozkan O; Gorgulu N; Yazici H; Turkmen A; Sever MS
Artif Organs; 2010 Aug; 34(8):E230-7. PubMed ID: 20618227
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
[TBL] [Abstract][Full Text] [Related]
10. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis.
Baur B; Oroszlan M; Hess O; Carrel T; Mohacsi P
Transplant Proc; 2011 Jun; 43(5):1853-61. PubMed ID: 21693289
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
15. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry-based pharmacodynamic monitoring after organ transplantation.
Dieterlen MT; Eberhardt K; Tarnok A; Bittner HB; Barten MJ
Methods Cell Biol; 2011; 103():267-84. PubMed ID: 21722807
[TBL] [Abstract][Full Text] [Related]
17. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[TBL] [Abstract][Full Text] [Related]
18. Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation.
Gude E; Gullestad L; Arora S; Simonsen S; Hoel I; Hartmann A; Holdaas H; Fiane AE; Geiran OR; Andreassen AK
J Heart Lung Transplant; 2010 Jun; 29(6):641-7. PubMed ID: 20304681
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients.
Vallin M; Guillaud O; Morard I; Gagnieu MC; Mentha G; Adham M; Morelon E; Boillot O; Giostra E; Dumortier J
Clin Transplant; 2011; 25(4):660-9. PubMed ID: 21158921
[TBL] [Abstract][Full Text] [Related]
20. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
